These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10205553)

  • 21. Arthritis: new agents herald more effective symptom management.
    Simon LS
    Geriatrics; 1999 Jun; 54(6):37-42; quiz 44. PubMed ID: 10377916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 23. Disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid disease.
    Subhash C; Agarwal AK; Rewari BB; Sangla KS; Vijay A
    J Assoc Physicians India; 1995 Mar; 43(3):232-3. PubMed ID: 11256928
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
    Pope JE; Hong P; Koehler BE
    J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 29. The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?
    Maini RN
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4():iv106-8. PubMed ID: 16239377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of rheumatoid arthritis].
    Babić-Naglić D
    Reumatizam; 2003; 50(2):22-7. PubMed ID: 15098369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
    Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Buckley C; Silman AJ; Symmons DP; Bruce IN
    J Rheumatol; 2005 Jan; 32(1):11-16. PubMed ID: 15700388
    [No Abstract]   [Full Text] [Related]  

  • 33. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.
    de Klerk E; van der Heijde D; Landewé R; van der Tempel H; van der Linden S
    J Rheumatol; 2003 Nov; 30(11):2469-75. PubMed ID: 14677194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study.
    Yee CS; Filer A; Pace A; Douglas K; Situnayake D; Rowe IF;
    Rheumatology (Oxford); 2003 Jul; 42(7):856-9. PubMed ID: 12730544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of rheumatoid arthritis.
    Simon LS
    Best Pract Res Clin Rheumatol; 2004 Aug; 18(4):507-38. PubMed ID: 15301984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-modifying antirheumatic drugs.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment and management of early RA: A primary care primer.
    Costenbader KH; Kountz DS
    J Fam Pract; 2007 Jul; 56(7 Suppl):S1-7; quiz S8. PubMed ID: 17605944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 39. How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments?
    Fries JF
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():35-40. PubMed ID: 10646489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
    Chan G; Goh F; Hodgson T; Hsu E; Johnstone D; Ly J; Platt T; Rodrigues E; Tsai W; Hider P; Gray A; Highton J
    N Z Med J; 2008 May; 121(1274):34-41. PubMed ID: 18535644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.